Physician profile
Jonathan D Rotker
NPI 1073547402
$1,231.31
in general payments reported to CMS, 2019-2025
14 companies · $25.04 in 2025
The $25.04 reported for 2025 was less than what a typical Gastroenterology (Internal Medicine) provider received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $294 · 2020: $100 · 2021: $86.63 · 2022: $122 · 2023: $571 · 2024: $32.90 · 2025: $25.04.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $629.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $628.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $598.89 | 2019-2024 | Rinvoq, Skyrizi, Linzess |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $169.57 | 2019-2023 | Xifaxan, Trulance |
| Gilead Sciences, INC. | $98.90 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $80.56 | 2019-2022 | |
| Pfizer INC. | $68.95 | 2019-2021 | |
| Genzyme Corporation | $45.10 | 2023 | |
| Merck Sharp & Dohme LLC | $42.42 | 2022 | |
| Redhill Biopharma INC. | $23.51 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $20.82 | 2020 | |
| Allergan, INC. | $18.29 | 2019 | |
| Braintree Laboratories, INC. | $18.11 | 2019 | |
| Ucb, INC. | $15.88 | 2020 | |
| Fresenius Kabi USA, LLC | $15.26 | 2023 | |
| Daiichi Sankyo INC. | $15.05 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jonathan Rotker listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.